MUHC unveils new Lung Cancer Navigation Program

NewsGuard 100/100 Score

A diagnosis of lung cancer can come as a hard blow. The disease has one of the highest mortality rates of all cancers and the sheer complexity of therapy - often involving radiation, chemotherapy and surgery - can leave patients feeling confused and isolated. To help these patients navigate through the complicated treatment process and medical appointments, the MUHC has unveiled its new Lung Cancer Navigation Program (LCNP).

The LCNP offers each patient the services of a nurse pivot, a highly-trained professional who "coaches" individuals, and their family, through the health care system. The program is expected to reduce delays in diagnosis and treatment of lung cancer, while alleviating the anxiety experienced by patients and their caregivers. Other anticipated benefits include easier access to outpatient care, fewer readmissions and shorter hospital stays.

"Our goal was to design a generic program that would facilitate patient access to hospital services," says Dr. David Mulder, Director of Thoracic Surgery at the MUHC. "While this type of program would benefit many categories of patients, we decided to start with lung cancer patients because they require the most complicated treatment." Lung cancer patients typically need to meet with specialists from as many as five disciplines in the course of therapy. On top of this, they are often elderly, so they have difficulty with transportation and other issues.

When they are enrolled in the LCNP, patients are given a phone number that connects them directly to one of the program's three pivot nurses. "These specially trained healthcare workers guide patients through their therapy," explains Andréanne Saucier, MUHC Associate Director of Nursing, Cancer Mission and Respiratory Services. "Each patient is carefully monitored daily through the use of a specific data base created to avoid gaps during the different steps of investigation and treatment." So far, over 200 patients have been enrolled in the program. The MUHC's Lung Cancer Tumour Board sees approximately 450 patients each year.

"I currently manage about 70 patients, all with advanced lung cancer," says Joannie Bernier, a nurse pivot with the LCNP. "We take care of symptoms management, and give these patients whatever support they need to deal with the system. For example, one of my patients became very ill and had to come to the ER. Before he came in, I alerted the triage nurse in ER, to help minimize his wait there. I also spoke to people in radiation oncology and palliative care, so they could reserve a bed for him. Our goal is to make things as easy as possible for patients and their families, and give them the help they need during this difficult time."

The LCNP also has a research component. "We are measuring the impact of the introduction of the program on access to services, particularly, whether the program reduces delays in the completion of investigation and the initiation of appropriate treatments," explains Dr. Anne Gonzalez, MUHC Interventional Respirologist and researcher. "A separate study will examine the effect of the LCNP on patient and family member outcomes, such as emotional distress and satisfaction with the healthcare services provided," adds Julie Dallaire, Clinical Nurse Specialist who has been heavily involved in the development of the LCNP.

"Providing seamless care to our patients is a top priority of the MUHC's Cancer Care Mission," adds Andréanne Saucier. "This programme helps us do that, and we'll be able to do it even better when all of our cancer care services are brought together at the new Comprehensive Cancer Centre at the Glen Campus."

Source: THE MONTREAL CHILDREN'S HOSPITAL

Source: MCGILL UNIVERSITY HEALTH CENTRE

Source:

THE MONTREAL CHILDREN'S HOSPITAL FOUNDATION

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study links air pollution to increased colorectal cancer risk through DNA changes